Idarubicin more cost-effective than daunorubicin?

Subjects

Subjects :

Daunorubicin therapeutic use
Hospital Charges
Hospital Costs
Humans
Leukemia, Myeloid drug therapy
Randomized Controlled Trials as Topic
Treatment Outcome
Cost-Benefit Analysis
Daunorubicin economics

Details

Language :

English

ISSN :

1170-7690

Volume :

1

Issue :

1

Database :

MEDLINE

Journal :

PharmacoEconomics

Publication Type :

Academic Journal

Accession number :

10147103

Full Text :

https://doi.org/10.2165/00019053-199201010-00012